La gestione del paziente diabetico tra presente e futuro
DOI:
https://doi.org/10.19156/abtpn.2017.0021Keywords:
Type 2 diabetes, Cardiovascular risk, Empagliflozin, End-stage renal diseaseAbstract
No abstract available (Diabetology)
No abstract available (Diabetology)
Copyright (c) 2017 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.